Cerebrovascular hemodynamics, gait, and falls in an elderly population: MOBILIZE Boston Study

F A Sorond1, A Galica, J M Serrador

  • 1Department of Neurology, Stroke Division, Brigham and Women's Hospital, 45 Francis St., Boston, MA 02115, USA. fsorond@partners.org

Neurology
|May 19, 2010
PubMed

Insights

Impaired cerebral blood flow regulation, specifically cerebral vasoreactivity to CO(2), is linked to slower walking speeds and an increased risk of falls in older adults.

Area of Science:

  • Neurology
  • Gerontology
  • Cardiovascular Physiology

Background:

  • Cerebral blood flow regulation is crucial for maintaining brain function.
  • Alterations in cerebral blood flow may contribute to mobility decline in the elderly.
  • Gait speed and falls are significant indicators of health and independence in older adults.

Purpose of the Study:

  • To investigate the association between cerebral blood flow regulation and gait speed.
  • To determine if impaired cerebral blood flow regulation predicts fall rates in community-dwelling seniors.

Main Methods:

  • Utilized transcranial Doppler ultrasound to measure cerebral blood flow velocity in 419 elderly individuals.
  • Assessed cerebral vasoreactivity to CO(2) and cerebral autoregulation during sit-to-stand maneuvers.
  • Measured gait speed and tracked fall incidence over time.

Main Results:

  • Cerebral vasoreactivity to CO(2) was significantly associated with slower gait speed.
  • Individuals with the lowest vasoreactivity had significantly slower gait speeds.
  • A trend towards a higher fall rate was observed in those with the lowest cerebral vasoreactivity.

Conclusions:

  • Impaired cerebral vasoreactivity to CO(2) is associated with reduced gait speed in the elderly.
  • This impairment may be a contributing factor to the development of falls in older populations.
Abstract

Related Concept Videos

Pharmacodynamics in Geriatric Patients: Effects of Age01:27

Pharmacodynamics in Geriatric Patients: Effects of Age

Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
Drug Dosing: Geriatric Patients01:15

Drug Dosing: Geriatric Patients

Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation01:21

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...